Orbec developed by DOR BioPharma Inc. is known to Improve Survival in Patients with Intestinal Graft-Versus-Host Disease. According to the results presented at the 2006 annual Tandem Bone Marrow Transplant Meeting of the American Society of Hematology, the oral agent Orbec (oral beclomethasone dipropionate) improves survival in patients diagnosed with intestinal graft-versus-host-disease.
Allogeneic bone marrow and stem cell transplantation are one of the most common treatment regimen...
| Currently you cannot purchase Orbeck as it might be not available for sale online or on local pharmacy. Subscribe below and we will inform you where and when you can order Orbeck |
| Orbeck Availability Subscription Form |
|
| |
| Note: We will email you when Orbeck is available for sale online or in pharmacy in your country. |
|
|
|